Study Stopped
no inclusion
Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache
UpSideDown
Effectiveness of Maintaining a Prone Position After Use of an Epidural Blood Patch for the Treatment of Post-dural Puncture Headache
2 other identifiers
interventional
3
1 country
1
Brief Summary
The main objective of this study is to assess the rate of recurrence of headache following a first blood patch where patients will be positioned in the prone position for an hour after each blood patch needed during this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2015
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 20, 2015
CompletedFirst Posted
Study publicly available on registry
April 27, 2015
CompletedStudy Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 23, 2016
CompletedFebruary 1, 2017
January 1, 2017
5 months
April 20, 2015
January 30, 2017
Conditions
Outcome Measures
Primary Outcomes (3)
Headache recurrence: yes/no
Headache recurrence defined by: presence of headaches that confine the mother to bed or affect her ability to take care of her baby
24 hours after first blood patch
Headache recurrence: yes/no
Headache recurrence defined by: presence of headaches that confine the mother to bed or affect her ability to take care of her baby
48 hours after first blood patch
Headache recurrence: yes/no
Headache recurrence defined by: presence of headaches that confine the mother to bed or affect her ability to take care of her baby
72 hours after first blood patch
Secondary Outcomes (7)
The number of blood patches required for each patient
Hospital discharge (expected average of 7 days)
Visual analog scale for pain
Baseline (day 0)
Visual analog scale for pain
24 hours after blood patch
Visual analog scale for pain
48 hours after blood patch
Visual analog scale for pain
72 hours after blood patch
- +2 more secondary outcomes
Study Arms (1)
The study population
EXPERIMENTALThe study population consists of adult women requiring an epidural blood patch for the treatment of post-dural puncture headache following vaginal delivery. Women who delivered by cesarean section are not included due to the discomfort of the prone position while there is an abdominal scar. Intervention: Prone position for 1 hour after blood patch
Interventions
After performing a blood patch, the patient will be placed in a prone position for 1 hour. This applies to all blood patches required during her hospitalization.
And indicated in inclusion criteria, patients in this protocol will have at least 1 blood patch. The amount of blood to be injected into the peridural space is fixed at 20 ml, but can be less in case of pain.
Eligibility Criteria
You may qualify if:
- The patient was informed about the implementation of the study, its objectives, constraints and patient rights
- The patient has signed the informed consent
- The patient must be affiliated or beneficiary of a health insurance plan
- The patient is available for follow up concerning her hospital stay
- The patient has a post-dural puncture headache after a vaginal delivery. The diagnosis of post-puncture headache is retained on the basis of a frankly postural character for the headache, triggered or exacerbated by orthostatic position and relieved by recumbency.
- The patient has an indication for a blood patch
You may not qualify if:
- The patient is participating in another interventional study, with the exception of the following studies: Papillo PMA (2013-A00538-37); DG-Postpartum (2013-A00277-38); ElastoMAP (2013-A01148-37); ElastoDéclench (2014-A00828-39); LXRs(2009-A00968-49); OASIS II (2013-A00773-42); GrossPath (2014-A01120-47).
- The patient is under guardianship, curatorship or under judicial protection
- The patient refuses to sign the consent
- It is not possible correctly inform the patient
- The patient is pregnant
- The patient has a contra-indication (or an incompatible combination therapy) for a necessary treatment in this study
- The patient was delivered by cesarean section
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, 30029, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Guy Aya, MD
Centre Hospitalier Universitaire de Nîmes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 20, 2015
First Posted
April 27, 2015
Study Start
December 1, 2015
Primary Completion
April 21, 2016
Study Completion
April 23, 2016
Last Updated
February 1, 2017
Record last verified: 2017-01